ELEVATE Study 410: Phase IV Study of Perampanel as Monotherapy or First Adjunctie Therapy in Patients Aged >= 4 Years with Focal _Onset Seizures (FOS) or Generalized Tonic-Clonic Seizures (GTCS) (P1-1.Virtual)

Pavel Klein,Omar Samad,Dinesh Kumar,Stella Ngo,Manoj Malhotra

NEUROLOGY（2022）

引用 0|浏览1

暂无评分

摘要

Sunday, April 24May 3, 2022Free AccessELEVATE Study 410: Phase IV Study of Perampanel as Monotherapy or First Adjunctive Therapy in Patients Aged ≥4 Years with Focal-Onset Seizures (FOS) or Generalized Tonic-Clonic Seizures (GTCS) (P1-1.Virtual)Pavel Klein, Omar Samad, Dinesh Kumar, Stella Ngo, and Manoj MalhotraAuthors Info & AffiliationsMay 3, 2022 issue98 (18_supplement)https://doi.org/10.1212/WNL.98.18_supplement.1194 Letters to the Editor

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要